Item
L-Valine (L-VALN)
The composition of this product is 98.5% to 101.5% L-Valine.
Acids / Alkalis
Attributes
- Gluten-free
- Ingredient declaration
Locations
Location name | Address |
---|---|
Fuller Enterprise USA Inc. | 1735 E. Grevillea Ct. Ontario, CA 91761 |
Tongliao Meihua Biological Sci-Tech Co., Ltd. | Mulitu Town, Keerqin District Tongliao, NM 028024 CHN |
Xinjiang Fufeng Biotechnologies Co., Ltd. | No. 188 Fangzheng East Street, Ganquanpu Economic and Technological Development Zone Urumqi, XJ 831302 CHN |
Documents
Type | Location | File name | Effective | Expiration |
---|---|---|---|---|
Allergens | Fuller Enterprise USA Inc. | Allergens.pdf | 8/15/2022 | 8/14/2024 |
3rd Party Audit Certificate | Fuller Enterprise USA Inc. | BRC - 20230203.pdf | 2/9/2022 | 2/3/2023 |
BSE - TSE | Fuller Enterprise USA Inc. | BSETSE and Non-ETO Statement.pdf | 10/11/2021 | 10/10/2024 |
Ingredient Statement | Xinjiang Fufeng Biotechnologies Co., Ltd. | Composition Statement.pdf | 7/19/2021 | 7/19/2022 |
Ingredient Statement | Fuller Enterprise USA Inc. | Composition Statement.pdf | 7/19/2021 | 7/19/2022 |
Country of Origin | Xinjiang Fufeng Biotechnologies Co., Ltd. | Country of Origin.pdf | 12/2/2019 | 12/1/2022 |
Country of Origin | Fuller Enterprise USA Inc. | Country of Origin.pdf | 9/25/2020 | 9/25/2023 |
Gluten | Fuller Enterprise USA Inc. | Gluten Free Statement.pdf | 10/11/2021 | 10/11/2022 |
GMO | Xinjiang Fufeng Biotechnologies Co., Ltd. | GMO Status.pdf | 12/2/2019 | 12/1/2021 |
GRAS/NDI/ODI Statement | Xinjiang Fufeng Biotechnologies Co., Ltd. | GRAS Statement.pdf | 5/13/2022 | 5/12/2025 |
HARPC Food Safety Plan (Item) | Xinjiang Fufeng Biotechnologies Co., Ltd. | HACCP Plan.pdf | 7/19/2021 | 7/18/2024 |
HACCP | Fuller Enterprise USA Inc. | HACCP Plan.pdf | 7/19/2021 | 7/18/2024 |
HACCP Process Flow Diagram | Fuller Enterprise USA Inc. | HACCP Plan.pdf | 7/19/2021 | 7/19/2023 |
Halal | Fuller Enterprise USA Inc. | Halal - 20260222.pdf | 2/22/2026 | |
Kosher | Fuller Enterprise USA Inc. | Kosher - 20221231.pdf | 12/31/2022 | |
Kosher | Xinjiang Fufeng Biotechnologies Co., Ltd. | Kosher - 2023.12.31.pdf | 12/14/2022 | 12/31/2023 |
Label Sample | Fuller Enterprise USA Inc. | Label Sample.pdf | 5/20/2022 | 5/20/2023 |
Lot Code | Xinjiang Fufeng Biotechnologies Co., Ltd. | Lot Code Explanation.pdf | 12/2/2019 | 12/1/2022 |
No Animal Ingredient Statement | Xinjiang Fufeng Biotechnologies Co., Ltd. | No Animal Ingredient Statement.pdf | 4/2/2022 | 4/2/2023 |
GMO | Fuller Enterprise USA Inc. | Non-GMO Statement.pdf | 8/11/2021 | 8/11/2023 |
Irradiation Status Statement | Xinjiang Fufeng Biotechnologies Co., Ltd. | Non-irradiated.pdf | 12/2/2019 | 12/1/2021 |
Irradiation Status Statement | Fuller Enterprise USA Inc. | Non-Irradiation Statement.pdf | 10/11/2021 | 10/11/2023 |
Item Questionnaire | Fuller Enterprise USA Inc. | NotApplicable_ItemQuestionnaire.pdf | 2/11/2023 | 2/10/2026 |
Nutrition | Fuller Enterprise USA Inc. | NotApplicable_Nutrition.pdf | 2/11/2023 | 2/10/2026 |
Suitability Requirements | Fuller Enterprise USA Inc. | NotApplicable_SuitabilityRequirements.pdf | 2/11/2023 | 2/10/2026 |
Pesticide | Fuller Enterprise USA Inc. | Pesticides Statement.pdf | 5/20/2022 | 5/19/2024 |
California Prop. 65 | Xinjiang Fufeng Biotechnologies Co., Ltd. | Prop 65 Statement.pdf | 7/19/2021 | 7/19/2023 |
California Prop. 65 | Fuller Enterprise USA Inc. | Prop 65 Statement.pdf | 7/19/2021 | 7/19/2023 |
Safety Data Sheet (SDS) | Xinjiang Fufeng Biotechnologies Co., Ltd. | SDS.pdf | 5/12/2021 | 5/11/2024 |
Safety Data Sheet (SDS) | Fuller Enterprise USA Inc. | SDS.pdf | 5/12/2021 | 5/11/2024 |
Residual Statement | Xinjiang Fufeng Biotechnologies Co., Ltd. | Solvent Free Statement.pdf | 2/9/2021 | 2/9/2022 |
Residual Statement | Fuller Enterprise USA Inc. | Solvent Free Statement.pdf | 5/20/2022 | 5/20/2023 |
Product Specification Sheet | Xinjiang Fufeng Biotechnologies Co., Ltd. | Specification - Standard.pdf | 12/2/2019 | 12/1/2022 |
Product Specification Sheet | Fuller Enterprise USA Inc. | Specification - Standard.pdf | 9/23/2019 | 9/22/2022 |
WADA/NSF/NFL Statement | Xinjiang Fufeng Biotechnologies Co., Ltd. | WADA Statement.pdf | 5/13/2022 | 5/12/2024 |
WADA/NSF/NFL Statement | Fuller Enterprise USA Inc. | WADA Statement.pdf | 5/20/2022 | 5/19/2024 |
CoA Sample | Xinjiang Fufeng Biotechnologies Co., Ltd. | X2011012.pdf | 11/10/2020 | 11/10/2022 |
CoA Sample | Fuller Enterprise USA Inc. | X2103011.pdf | 3/6/2021 | 3/6/2023 |